Market Research ReportJul 31, 2026

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market Research Report: Size, Share, Trend Analysis By Region (NA, Europe, APAC) - Growth Outlook & Industry Forecast To 2025

Vertical: HealthcareBase Year: 202579 Sections

Book Demo

Executive Summary

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market — Snapshot

Market Size (2025)
$4.14T
Projected (2025)
$4.14T
CAGR (2020–2025)
6.4%
Key Players
100+

This report covers North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market with forecasts from 2020 to 2025. 100 key companies are profiled.

Key Insight

The North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market is projected to grow at a CAGR of 6.4% from 2020 to 2025.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 3 regions: NA, Europe, APAC.
Market Segmentation: The market is analyzed across 1 segments: Cancer Type. Forecasts are provided for each segment from 2020 to 2025.
Competitive Landscape: 100 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Million)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market — Growth Trajectory

Analysis of North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market from 2020 to 2025. Covers NA, Europe, APAC.

Market Size Trend (USD Million)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Segmentation The North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market is analyzed across multiple dimensions with regional breakdowns.

Geographic Analysis

Regional market breakdown

NA market size reached $558.21B in 2020 and is projected to reach $587.13B by 2025, growing at a CAGR of 1.0%.
Europe market size reached $1.05T in 2020 and is projected to reach $1.11T by 2025, growing at a CAGR of 1.2%.

APAC market size reached $1.44T in 2020 and is projected to reach $2.44T by 2025, growing at a CAGR of 11.2%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2025
Historical Period
2020 – 2024
Forecast Period
2025 – 2025
Primary Interviews
150+

Research Process

Historical data (2020–2025) and forecast period (2025–2025)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Quantitative Analysis

Regional Breakdown

Regional market breakdown for North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market.

Regional Market Size (USD Million)

Market estimates by geography (2025)

Europe

APAC

USD Million

InsightAPAC leads with $2.44T by 2025.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2020	2025	2025	CAGR	SHARE
NA	$558.21B	$584.18B	$587.13B	1.0%	14%
Europe	$1.05T	$1.08T	$1.11T	1.2%	27%
APAC	$1.44T	$2.36T	$2.44T	11.2%	59%
Total	$3.04T	$4.03T	$4.14T	6.4%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2025)

Cancer Type

036372610891452

Cancer Type100%

Total Market Size

$4.14T

Market by Segment (2025)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Cancer Type	$1.32T	1.1%	100%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market — Key Findings

Analytical insights on North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market is projected to reach $4.14T by 2025, growing at 6.4% CAGR. The Cancer Type segment holds the largest share.

Market Dynamics

The North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market encompasses 3 key regions and 1 market segments, with the study period spanning 2020 to 2025. The market demonstrates a 6.4% compound annual growth rate, reflecting strong underlying demand fundamentals.

The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.

Competitive Landscape

This report profiles 100 key companies operating in the North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market, covering market positioning, product portfolios, and recent developments.

Leading players include , and 95 others.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2025)

Value (USD Million)

Cancer Type

Companies

Key companies profiled in North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market

Profiles of 100 companies operating in the North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 100 of 100 companies

Novavax, I

Novavax, Inc.

Healthcare

Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa

Cleveland Biolabs, Inc

Healthcare

Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.

SIGA Technologies

Company Headquarters: New York, US Founded: 1995 Workforce: ~50 Company Working: SIGA Technologies (SIGA) is a pharmaceutical business at the commercialization stage that develops and offers antiviral treatments for smallpox, monkeypox, cowpox, and vaccinia complications. The company has an established research and development collaboration with US federal entities. It provides countermeasures to the Strategic National Stockpile (SNS) and the Department of Defense (DoD). TPOXX ("oral TPOXX," also known as "tecovirimat" in certain overseas markets) is the Company's lead product, which it distributes to the US government and international governments (including government-affiliated entities). In addition, the Company sells TPOXX intravenous formulation ("IV TPOXX") to the US Government

Company Headquarters: Maryland, US Founded: 1997 Workforce: ~50 Company Working: Altimmune is a clinical-stage biopharmaceutical business focusing on treating obesity and liver illnesses. The business is working on HepTcell, an immunotherapeutic drug aimed at providing a functional cure for chronic hepatitis B. The company was formed through the merger of PharmAthene, Inc. ("PharmAthene") with the company formerly known as Altimmune

Bavarian Nordic

Company Headquarters: Denmark, Europe Founded: 1992 Workforce: ~1000 Company Working: Bavarian Nordic is a fully integrated vaccines company focused on R&D innovation, vaccine manufacturing, and vaccine commercialization. It has built a commercial infrastructure with a presence in key countries in Europe and the US in order to drive profitable expansion of its expanding vaccine portfolio. The company is an expert in the production of live viral vaccines, and the fill & finish capabilities has enabled end-to-end commercial-scale production

Navidea Biopharmaceuticals Inc

Healthcare

Company Headquarters: Ohio, US Founded: 1983 Workforce: ~ 50 Company Working: Navidea Biopharmaceuticals Inc (Navidea) manufacturer and distributor of precision immunodiagnostic agents and immunotherapeutic. It operates through mainly three segments such as diagnostics, therapeutics, and corporate. Tc99m tilmanocept for Kaposi's, NAS, cardiovascular illnesses, sentinel node biopsy, and solid tumors lymphatic mapping, as well as NAV4694 for Alzheimer's Disease, are among its pipeline products. The business is utilizing its Manocept platform to create a variety of precision-targeted solutions that will enhance patient care by locating illness pathways and sites and facilitating accurate clinical decision-making. Furthermore, it operates in the US and the UK.

Page 1 of 17

…

Go to page

Charts

2 interactive charts drawn from the North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.

Pro

Healthcare & PharmaJul 31, 2026

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market By Cancer Type

Pro

Healthcare & PharmaJul 31, 2026

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market By Region

Browse All Charts

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market Research Report: Size, Share, Trend Analysis By Region (NA, Europe, APAC) - Growth Outlook & Industry Forecast To 2025

Starting from

$4,950

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market

North America, Europe, and Asia-Pacific NGS-Based Solid Tumor Cancer Testing Market Research Report: Size, Share, Trend Analysis By Region (NA, Europe, APAC) - Growth Outlook & Industry Forecast To 2025

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Market Size Trend (USD Million)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Competitive Landscape

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Market Performance Trend

Market Size Trend (USD Million)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Competitive Landscape

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription